NASDAQ: TELA - TELA Bio, Inc.

Rentabilité sur six mois: -36.88%
Secteur: Healthcare

Calendrier des promotions TELA Bio, Inc.

Calendrier avancé Graphique simple
Financial Markets by TradingView

À propos de l'entreprise

TELA Bio, Inc., a commercial-stage medical technology company, focuses on providing soft-tissue reconstruction solutions that optimize clinical outcomes by prioritizing the preservation and restoration of the patient's anatomy.

plus de détails
The company provides a portfolio of OviTex Reinforced Tissue Matrix (OviTex) products for hernia repair and abdominal wall reconstruction; and OviTex PRS Reinforced Tissue Matrix products to address the unmet needs in plastic and reconstructive surgery, as well as OviTex for Laparoscopic and Robotic Procedures, a sterile reinforced tissue matrix derived from ovine rumen with polypropylene fiber intended to be used in laparoscopic and robotic-assisted hernia surgical repairs. It markets its products through a single direct sales force, principally in the United States. TELA Bio, Inc. was incorporated in 2012 and is headquartered in Malvern, Pennsylvania.
Ajouter à la liste de comparaison
Ajouter à la liste de surveillance
Ajouter au portefeuille
Ajouter un avis de prix

EBITDA -0.0188
EV/EBITDA -6.69
IPO date 2019-11-08
ISIN US8723811084
Industry Health Care Equipment & Supplies
P/BV 4.55
P/S 9.12
Sector Health Care
Валюта usd
Валюта отчета usd
Выручка 0.0154
Сайт https://www.telabio.com
Цена ао 5.56
Число акций ао 0.02287 млрд
Changement de prix par jour: -0.3425% (2.92)
Changement de prix par semaine: +2.11% (2.85)
Changement de prix par mois: -3.96% (3.03)
Changement de prix sur 3 mois: +10.65% (2.63)
Changement de prix sur six mois: -36.88% (4.61)
Changement de prix par an: -56.04% (6.62)
Evolution du prix sur 3 ans: -77.34% (12.84)
Evolution du prix sur 5 ans: -75.23% (11.75)
Evolution des prix sur 10 ans: 0% (2.91)
Evolution des prix depuis le début de l'année: +5.43% (2.76)
Tous les paramètres

Sous-estimation

Nom Signification Grade
P/S 2.55 6
P/BV 7.9 1
P/E 0 0
EV/EBITDA -3.35 0
Total: 4.63

Efficacité

Nom Signification Grade
ROA, % -59.79 0
ROE, % -247.15 0
Total: 0

Dividendes

Nom Signification Grade
Div yield, % 0 0
DSI 0 0
Total: 0

Devoir

Nom Signification Grade
Debt/EBITDA -0.9495 10
Total: 7.8

Impulsion de croissance

Nom Signification Grade
Rentabilité Revenue, % 279.56 10
Rentabilité Ebitda, % 116.13 10
Rentabilité EPS, % -86.03 0
Total: 7
Plus de détails

Établissements Volume Partager, %
Essex Woodlands Management Inc. 4110709 16.68
Orbimed Advisors LLC. 2835542 11.5
First Light Asset Management, LLC 2554641 10.36
Nantahala Capital Management, LLC 2195732 8.91
AIGH Capital Management LLC 1377945 5.59
Blackrock Inc. 1078056 4.37
Vanguard Group Inc 998853 4.05
Pentwater Capital Management LP 990000 4.02
SILVERARC CAPITAL MANAGEMENT, LLC 795080 3.23
Federated Hermes, Inc. 712300 2.89

ETF Partager, % Rentabilité pour l'année, % Dividendes, %
Jacob Forward ETF 2.05852 43.03 0.15284
iShares Micro-Cap ETF 0.01069 13.79 1.54048



Superviseur Titre d'emploi Paiement Année de naissance
Mr. Antony Koblish Co-founder, President, CEO & Director 1.03M 1966 (59 années)
Mr. Roberto E. Cuca J.D. CFO & COO 674.78k 1968 (57 années)
Mr. Paul Talmo Chief Technology Officer 595.67k 1972 (53 année)
Ms. Megan Smeykal VP, Corporate Controller, Chief Accounting Officer & Principal Accounting Officer N/A 1976 (49 années)
Mr. D. Taylor Ocasio General Counsel & Corporate Secretary N/A
Ms. Jennifer Lou Armstrong Senior Vice President of Human Resources N/A 1970 (55 années)
Mr. Gregory A. Firestone Chief Commercial Officer N/A 1959 (66 années)
Mr. Michael Leonard Senior Vice President of Technical Operations N/A
Mr. Peter C. Murphy Chief Commercial Officer 542.34k 1973 (52 année)
Louisa Smith Investor Relations Contact Officer N/A

Adresse: United States, Malvern. PA, 1 Great Valley Parkway - ouvrir dans Google Maps, ouvrir les cartes Yandex
Site web: https://www.telabio.com